Skip to main content
iDNA Genomics Public Ltd logo

iDNA Genomics Public Ltd — Investor Relations & Filings

Ticker · IDNA ISIN · CY0109800710 LEI · 2549006HMJWPY9CIB812 CSE Human health and social work activities
Open in API
Filings indexed 80 across all filing types
Latest filing 2022-05-23 Director's Dealing
Country CY Cyprus
Listing CSE IDNA

About iDNA Genomics Public Ltd

https://idnagenomics.com/en/

iDNA Genomics Public Ltd is a biotechnology company specializing in genetic analysis and precision medicine. It develops and provides DNA tests focused on three main areas: pharmacogenetics, which analyzes how genes affect a person's response to drugs; preventive medicine, which screens for genetic predispositions to diseases; and wellness genomics, which informs personalized nutrition and exercise plans. The company's product portfolio includes tests for cardiovascular health and responses to central nervous system medications. Genetic analysis is performed in its certified laboratories, supported by a proprietary bioinformatics platform and an artificial intelligence database that is continuously updated with recent scientific data to ensure accuracy. iDNA Genomics also provides the myEMR online platform for individuals and healthcare professionals to register test kits and manage genetic results.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing Classification · 98% confidence The document text is in Greek and appears to be a formal notification regarding a change in shareholding ('ΕΝΗΜΕΡΩΣΗ ΓΙΑ ΑΠΟΚΤΗΣΗ Ή ΔΙΑΘΕΣΗ ΣΗΜΑΝΤΙΚΗΣ ΣΥΜΜΕΤΟΧΗΣ' - Notification for Acquisition or Disposal of Significant Participation). It details the acquirer (ΦΩΤΗΣ ΣΑΚΕΛΛΑΡΙΔΗΣ), the issuer (IDNA GENOMICS PUBLIC LTD), the number of shares, and the resulting percentage of voting rights before and after the transaction (e.g., from 10% to 9.808%). This type of filing specifically reports transactions by individuals or entities that cross significant ownership thresholds, which directly corresponds to the definition of Major Shareholding Notification.
2022-05-23 Greek (modern)
Director's Dealing 2022
Director's Dealing Classification · 100% confidence The document is explicitly titled 'MANAGERS' TRANSACTIONS' and 'Notification of Transactions by Persons Discharging Managerial Responsibilities'. It details a transaction (SELL) involving shares by an individual identified as a DIRECTOR (SAKELLARIDIS FOTIOS) under Article 19 of the EU Market Abuse Regulation. This directly corresponds to the definition of Director's Dealing (insider trades) provided by the code DIRS.
2022-05-23 English
AGM Information 2022
AGM Information Classification · 100% confidence The document is explicitly titled "ΕΙΔΟΠΟΙΗΣΗ ΕΤΗΣΙΑΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ ΤΩΝ ΜΕΤΟΧΩΝ" (Notice of Annual General Meeting of Shareholders) for iDNA GENOMICS PUBLIC LTD. It details the date, time, and agenda for the meeting, which includes reviewing the Annual Report, board re-elections, and auditor reappointment. This content directly corresponds to the purpose of an Annual General Meeting (AGM) notification. Therefore, the classification is AGM-R.
2022-05-06 Greek (modern)
Audit Report / Information 2021
Audit Report / Information Classification · 98% confidence The document text contains a table of contents listing 'Έκθεση Διαχείρισης' (Management Report), 'Έκθεση ανεξάρτητου ελεγκτή' (Independent Auditor's Report), and various financial statements ('Ενοποιημένη κατάσταση αποτελεσμάτων', 'Ενοποιημένη κατάσταση χρηματοοικονομικής θέσης', etc.) for the period ending December 31, 2021. The presence of a detailed 'Έκθεση ανεξάρτητου ελεγκτή' (Independent Auditor's Report) which includes a 'Γνώμη με Επιφύλαξη' (Qualified Opinion) and discusses key audit matters, alongside the full financial statements, strongly indicates this is a comprehensive annual filing. Although it includes the Management Report, the core component defining this document type is the audited financial statements and the auditor's opinion. This aligns best with the definition of an Annual Report (10-K), even though the text is in Greek and the specific form name '10-K' is US-centric. Given the comprehensive nature covering the full fiscal year and including the auditor's opinion, '10-K' is the most appropriate classification among the provided options for a full annual financial report. FY 2021
2022-04-29 Greek (modern)
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a formal announcement dated March 10th, 2022, addressed to the Cyprus Stock Exchange. The topic is the impact of the Russia-Ukraine crisis and related sanctions on the company's operations and financial results. It discusses potential risks and uncertainties but concludes that no major impact is currently expected. This type of forward-looking statement regarding geopolitical risks and their potential effect on business operations and financial outlook is characteristic of a general regulatory disclosure or an update on material risks, rather than a specific financial report (like 10-K or IR) or a management discussion (MDA). Since it is a general announcement concerning material risks that doesn't fit the specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements.
2022-03-10 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.